GS0051: Drug delivery agents in the form of oral soluble film, sublingual film, and transmucosal film that facilitate the delivery of prescription pharmaceutical drug preparations; films dissolvable in the mouth for the oral delivery of prescription pharmaceutical drug preparations; pharmaceutical preparations for the prevention and treatment of neurological, cardiopulmonary, viral, metabolic, endocrine, musculoskeletal, genitourinary, gastrointestinal, oncological, autoimmune, hormonal, central nervous system, and psychiatric related diseases and disorders; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for the treatment of epilepsy, seizure disorders, and psychiatric disorders; Pharmaceutical preparations, namely, anticonvulsants, antiseizure medications, psychotropics, benzodiazepines, and mood stabilizing medications
GS0421: Research and development of pharmaceutical preparations and medicines; Conducting early evaluations in the field of new pharmaceuticals; Medical and scientific research in the fields of pharmaceuticals, medicine, and therapeutics; Consulting services in the fields of pharmaceutical research and development
Case File Event Statements
2/1/2022 - 3 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
1/31/2022 - 3 years ago
1 - NEW APPLICATION ENTEREDType:NWAP
3/16/2022 - 2 years ago
3 - ASSIGNED TO EXAMINERType:DOCK
3/24/2022 - 2 years ago
4 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
4/6/2022 - 2 years ago
5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
4/26/2022 - 2 years ago
6 - PUBLISHED FOR OPPOSITIONType:PUBO
4/26/2022 - 2 years ago
7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
6/21/2022 - 2 years ago
8 - NOA E-MAILED - SOU REQUIRED FROM APPLICANTType:NOAM
8/25/2022 - 2 years ago
9 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVEDType:REAP